Last Posted: Sep 05, 2019
- Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies.
Wu Joseph C et al. Circulation research 2019 Aug 125(6) 653-658 - Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy.
Mathew J et al. Clinical genetics 2018 93(2) 310-319 - Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids).
Norrish Gabrielle et al. JAMA cardiology 2019 Aug - Inherited Cardiac Arrhythmias and Channelopathies.
Kline Jessica et al. The Medical clinics of North America 2019 Sep 103(5) 809-820 - Respiratory care in familial dysautonomia: Systematic review and expert consensus recommendations.
Kazachkov Mikhail et al. Respiratory medicine 2018 14137-46 - Short QT Syndrome: A Comprehensive Genetic Interpretation and Clinical Translation of Rare Variants.
Campuzano Oscar et al. Journal of clinical medicine 2019 Jul 8(7) - Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants.
Monasky Michelle M et al. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2019 Jul - Cardiovascular genomics and sudden cardiac death in the young.
Isbister Julia et al. Australian journal of general practice 2019 Mar 48(3) 90-95 - European recommendations integrating genetic testing into multidisciplinary management of sudden cardiac death.
Fellmann Florence et al. European journal of human genetics : EJHG 2019 Jun - Family screening for hypertrophic cardiomyopathy: Is it time to change practical guidelines?
Lafreniere-Roula Myriam et al. European heart journal 2019 Jun
.png)
No hay comentarios:
Publicar un comentario